Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
CD34-selected alloHCT is associated with high chronic GVHD relapse-free survival in AML and MDS. Higher HCT-CI and HCT-CI/age are associated with higher NRM and lower OS in CD34-selected alloHCT. HCT-CI and HCT-CI/age may be used to select appropriate patients for CD34-selected alloHCT.